LYNN ENGLE-LANEVE, O.D.
Corneal and Contact Management Optometrist in CHARLESTON, West Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
LYNN ENGLE-LANEVE, O.D. filed 327 Medicare Part D claims in 2023 as a Corneal and Contact Management Optometrist in CHARLESTON, West Virginia, prescribing 44% generic.
- 327
- Part D claims, 2023
- 44%
- generic prescribing
- $751.83
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
LYNN ENGLE-LANEVE, O.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
327 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about LYNN ENGLE-LANEVE, O.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in West Virginia
How Corneal and Contact Management Optometrist compares to other specialties among West Virginia providers
Corneal and Contact Management Optometrist share within West Virginia
Corneal and Contact Management Optometrist is one of the more visible NUCC categories in West Virginia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Corneal and Contact Management Optometrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Corneal and Contact Management Optometrist ABMS/AOA estimate
Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Corneal and Contact Management Optometrist US NPIs
Specialty board-certified rate — Corneal and Contact Management Optometrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
LYNN ENGLE-LANEVE, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 300 ASSOCIATION DR, CHARLESTON, WV, 25311, with a listed phone of (304) 342-5900. NPI 1659367498 was issued on 09/27/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ENGLE-LANEVE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 327 prescription claims written by this provider, covering 115 Medicare beneficiaries and totaling roughly $204K in drug spend, split 56% brand-name and 44% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1659367498 |
|---|---|
| Specialty | Corneal and Contact Management Optometrist |
| Credentials | O.D. |
| Gender | Female |
| NPI Issued | 09/27/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm LYNN ENGLE-LANEVE, O.D.'s current license status, disciplinary history, and board certifications with the West Virginia Board of Medicine in West Virginia before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where LYNN ENGLE-LANEVE, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LYNN ENGLE-LANEVE, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$752
Largest payer
SUN PHARMACEUTICAL INDUSTRIES INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
56% brand-name claims vs 44% generic, on 327 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 661
- Total Day Supply
- 19,277
- Brand vs Generic
- 56% brand / 44% generic
- Brand Drug Cost
- $198K
- Generic Drug Cost
- $6K
- Antibiotic Claims
- 48
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 0.90
- Gender Split
- 65% female / 35% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What LYNN ENGLE-LANEVE, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Restasis
Restasis
73 claims
- Doxycycline Monohy…
Doxycycline Monohydrate
41 claims
- Latanoprost 26
Latanoprost
26 claims
- Timolol Maleate 26
Timolol Maleate
26 claims
- Xiidra 17
Xiidra
17 claims
- Dorzolamide Hcl 13
Dorzolamide Hcl
13 claims
- Lumigan 13
Lumigan
13 claims
- Brimonidine Tartrate 11
Brimonidine Tartrate
11 claims
| Drug | Claims |
|---|---|
| Restasis Cyclosporine | 73 |
| Doxycycline Monohydrate | 41 |
| Latanoprost | 26 |
| Timolol Maleate | 26 |
| Xiidra Lifitegrast | 17 |
| Dorzolamide Hcl | 13 |
| Lumigan Bimatoprost | 13 |
| Brimonidine Tartrate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Corneal and Contact Management Optometrist Overview
How LYNN ENGLE-LANEVE, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.
LYNN ENGLE-LANEVE, O.D.'s 327 claims are above the specialty average of 235.
Nearby Corneal and Contact Management Optometrist Providers in West Virginia
Other clinicians with the same primary specialty enrolled in West Virginia, drawn from the same CMS NPPES roster as ENGLE-LANEVE.
Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore West Virginia
Frequently Asked Questions
What is LYNN ENGLE-LANEVE, O.D.'s specialty? ▼
How much does LYNN ENGLE-LANEVE, O.D. prescribe under Medicare Part D? ▼
Where is LYNN ENGLE-LANEVE, O.D. located? ▼
What is LYNN ENGLE-LANEVE, O.D.'s NPI number? ▼
Does LYNN ENGLE-LANEVE, O.D. prescribe more brand-name or generic drugs? ▼
How many Corneal and Contact Management Optometrist providers are there in the US? ▼
What drugs does LYNN ENGLE-LANEVE, O.D. prescribe most often? ▼
Does LYNN ENGLE-LANEVE, O.D. accept Medicare? ▼
How can I verify LYNN ENGLE-LANEVE, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology